Blay JY - Search Results

1

Tumor necrosis factor as an autocrine growth factor for neuroblastoma.

Goillot E, Combaret V, Ladenstein R, Baubet D, Blay JY, Philip T, Favrot MC. Goillot E, et al. Among authors: blay jy. Cancer Res. 1992 Jun 1;52(11):3194-200. Cancer Res. 1992. PMID: 1317260

2

High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases.

Dumontet C, Biron P, Bouffet E, Blay JY, Meckenstock R, Chauvin F, Philip I, Clavel M, Brunat-Mentigny M, Philip T. Dumontet C, et al. Among authors: blay jy. Bone Marrow Transplant. 1992 Nov;10(5):405-8. Bone Marrow Transplant. 1992. PMID: 1464000

3

[Analysis of changes in serum levels of TNF, IL-1 and IL-6 during administration of IL-2. Correlation with clinical response to treatment].

Blay JY, Négrier S, Combaret V, Merrouche Y, Mercatello A, Moskovtchenko JF, Philip T, Favrot M. Blay JY, et al. Bull Cancer. 1992;79(1):55-65. Bull Cancer. 1992. PMID: 1520953 French.

4

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.

Blay JY, Negrier S, Combaret V, Attali S, Goillot E, Merrouche Y, Mercatello A, Ravault A, Tourani JM, Moskovtchenko JF, et al. Blay JY, et al. Cancer Res. 1992 Jun 15;52(12):3317-22. Cancer Res. 1992. PMID: 1596890

5

Management of pediatric non-Hodgkin's lymphoma.

Blay JY, Louis D, Bouffet E, Thiesse P, Biron P, Favrot MC, Brunat-Mentigny M, Philip T. Blay JY, et al. Blood Rev. 1991 Jun;5(2):90-7. doi: 10.1016/0268-960x(91)90040-j. Blood Rev. 1991. PMID: 1912759 Review.

6

TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.

Favrot M, Combaret V, Blay JY, Capdeville R, Zhou DC, Clapisson G, Chouaib S, Franks CR, Philip T. Favrot M, et al. Among authors: blay jy. Eur Cytokine Netw. 1990 Oct-Nov;1(4):221-7. Eur Cytokine Netw. 1990. PMID: 2104243

7

Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.

Favrot M, Capdeville R, Combaret V, Zhou DC, Clapisson G, Banchereau J, Franks CR, Chouaib S, Blay JY, Philip T. Favrot M, et al. Among authors: blay jy. Eur Cytokine Netw. 1990 Aug-Sep;1(3):141-7. Eur Cytokine Netw. 1990. PMID: 2129798

8

Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells.

Robinet E, Branellec D, Termijtelen AM, Blay JY, Gay F, Chouaib S. Robinet E, et al. Among authors: blay jy. J Immunol. 1990 Jun 15;144(12):4555-61. J Immunol. 1990. PMID: 2161875

9

[Involvement of tumor necrosis factor in the generation of LAK killer cells].

Chouaib S, Blay JY. Chouaib S, et al. Among authors: blay jy. Pathol Biol (Paris). 1990 Jan;38(1):47-52. Pathol Biol (Paris). 1990. PMID: 2308780 French.

10

Functional interactions between interleukin-4, interleukin-2, and tumor necrosis factor-alpha for lymphokine-activated killer cell generation.

Blay JY, Branellec D, Robinet E, Gay F, Chouaib S. Blay JY, et al. J Clin Lab Anal. 1990;4(1):54-8. doi: 10.1002/jcla.1860040111. J Clin Lab Anal. 1990. PMID: 2313467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,028 results

Search Page

Filters